Pharmaceutical Industry Blog

Last Updated: June 2, 2026 TL;DR: Ethylmethylhydroxypyridine Succinate Injection — a sterile clear solution of the antioxidant and membrane-protective neuroprotective emoxypine succinate, supplied most commonly as a 50 mg/mL solution in 2 mL and 5 mL ampoules for slow intravenous or intramuscular administration — is widely used in the CIS and allied markets for acute and chronic cerebral circulatory disorders, including the acute phase of ischaemic cerebrovascular accident, d

Last Updated: June 2, 2026 TL;DR: Micafungin for Injection — a sterile lyophilised powder of the echinocandin antifungal micafungin sodium, supplied most commonly as 50 mg and 100 mg vials for reconstitution and dilution before slow intravenous infusion — is a front-line agent for serious invasive fungal disease: invasive candidiasis and candidaemia, oesophageal candidiasis, and prophylaxis of Candida infection in patients undergoing haematopoietic stem-cell transplantation o

Last Updated: June 1, 2026 TL;DR: Caspofungin for Injection — a sterile lyophilised powder of the echinocandin antifungal caspofungin acetate, supplied most commonly as 50 mg and 70 mg vials for reconstitution and dilution before slow intravenous infusion — is a front-line agent for serious invasive fungal disease: invasive candidiasis and candidaemia, invasive aspergillosis in patients refractory to or intolerant of other therapies, oesophageal candidiasis, and empirical ant

Last Updated: June 1, 2026 TL;DR: Vancomycin for Injection — a sterile lyophilised powder of the glycopeptide antibiotic vancomycin hydrochloride, supplied most commonly as 500 mg and 1 g vials for reconstitution and dilution before slow intravenous infusion — is a cornerstone agent against serious Gram-positive infection, including methicillin-resistant Staphylococcus aureus (MRSA), coagulase-negative staphylococci, enterococci and resistant streptococci: bacteraemia, infect

Teicoplanin for Injection — a sterile lyophilised powder of the glycopeptide antibiotic teicoplanin, supplied most commonly as 200 mg and 400 mg vials for reconstitution with water for injection — is a front-line agent against serious Gram-positive infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA) and other resistant staphylococci and streptococci: infective endocarditis, bone and joint infection

Aminophylline Injection — a sterile parenteral solution of the methylxanthine bronchodilator aminophylline (the theophylline-ethylenediamine complex, roughly 80% theophylline), supplied most commonly as 25 mg/mL in 10 mL ampoules (250 mg/10 mL) — is a long-established intravenous bronchodilator for acute severe asthma and acute exacerbations of chronic obstructive pulmonary disease that do not respond adequately to inhaled bronchodilators, and for apnoea of prematurity in the